0001104659-21-123286.txt : 20211005
0001104659-21-123286.hdr.sgml : 20211005
20211005185144
ACCESSION NUMBER: 0001104659-21-123286
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211004
FILED AS OF DATE: 20211005
DATE AS OF CHANGE: 20211005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUFFOLO ROBERT R
CENTRAL INDEX KEY: 0001187308
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38630
FILM NUMBER: 211308221
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aridis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001614067
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320074500
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 983 UNIVERSITY AVENUE, BLDG. B
CITY: LOS GATOS
STATE: CA
ZIP: 95032
BUSINESS PHONE: (408) 385-1742
MAIL ADDRESS:
STREET 1: 983 UNIVERSITY AVENUE, BLDG. B
CITY: LOS GATOS
STATE: CA
ZIP: 95032
4
1
tm2129291-5_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-10-04
0
0001614067
Aridis Pharmaceuticals, Inc.
ARDS
0001187308
RUFFOLO ROBERT R
C/O ARIDIS PHARMACEUTICALS, INC.
983 UNIVERSITY AVENUE, BLDG. B
LOS GATOS
CA
95032
1
0
0
0
Stock Options
3.60
2021-10-04
4
A
0
7000
0
A
2031-10-04
Common Stock
7000
49791
D
The stock options vest in equal installments over 12 months, beginning on October 4, 2021.
/s/ Robert Ruffolo
2021-10-05